Myriad Genetics, Inc.
Myriad Genetics, Inc. MYD.DE Peers
See (MYD.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MYD.DE | €26.72 | N/A | 2.2B | -256.92 | -€0.10 | N/A |
| PHIA.DE | €48.00 | N/A | 43.4B | 13.73 | €3.50 | +4.16% |
| BTL.DE | €58.80 | N/A | 29.6B | 30.31 | €1.94 | N/A |
| SRT.DE | €176.40 | -0.45% | 13.7B | 127.83 | €1.38 | +0.41% |
| SRT3.DE | €219.20 | -0.95% | 13.6B | 160.00 | €1.37 | +0.33% |
| AFX.DE | €58.25 | -2.43% | 5.1B | 32.91 | €1.77 | +1.01% |
| FIE.DE | €55.80 | -1.06% | 4.7B | 30.83 | €1.81 | +1.77% |
| 1SXP.F | €28.65 | -0.52% | 4.3B | 32.19 | €0.89 | +0.56% |
| GXI.DE | €64.05 | +5.00% | 2.2B | 28.09 | €2.28 | +2.05% |
| 2B4.F | €23.16 | +0.52% | 1.5B | 136.24 | €0.17 | N/A |
Stock Comparison
MYD.DE vs PHIA.DE Comparison
MYD.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MYD.DE stands at 2.2B. In comparison, PHIA.DE has a market cap of 43.4B. Regarding current trading prices, MYD.DE is priced at €26.72, while PHIA.DE trades at €48.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MYD.DE currently has a P/E ratio of -256.92, whereas PHIA.DE's P/E ratio is 13.73. In terms of profitability, MYD.DE's ROE is -0.12%, compared to PHIA.DE's ROE of +0.03%. Regarding short-term risk, MYD.DE and PHIA.DE have similar daily volatility (0.00).